Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,052Revenue $M37.2Net Margin (%)-456.6Altman Z-Score-7.4
Enterprise Value $M1,266EPS $-0.8Operating Margin %-326.7Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-456.5Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsY
Price/Sales25.55-y EBITDA Growth Rate %--Current Ratio3.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-54.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M228ROIC % (ttm)-113.6Gross Margin Increase y-yN

Gurus Latest Trades with EXEL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXELCharles Brandes 2015-12-31 Reduce$4.79 - $6.33
($5.59)
$ 4.61-18%Reduce -44.88%14,000
EXELCharles Brandes 2015-06-30 Buy $2.57 - $4.03
($3.24)
$ 4.6142%New holding25,400
EXELFirst Eagle Investment 2014-06-30 Sold Out -0.0038%$3.22 - $3.8
($3.45)
$ 4.6134%Sold Out0
EXELFirst Eagle Investment 2014-03-31 Reduce-0.01%$3.38 - $8.24
($6.84)
$ 4.61-33%Reduce -65.91%400,000
EXELFirst Eagle Investment 2012-09-30 Add0.02%$4.28 - $6.45
($5.29)
$ 4.61-13%Add 422.58%1,175,800
EXELFirst Eagle Investment 2012-03-31 Add$4.49 - $6.47
($5.14)
$ 4.61-10%Add 125.00%225,000
EXELFirst Eagle Investment 2011-12-31 Buy $3.95 - $7.81
($5.01)
$ 4.61-8%New holding100,000
EXELCarl Icahn 2011-09-30 Sold Out -0.43%$5.5 - $9.22
($7.34)
$ 4.61-37%Sold Out0
EXELFirst Eagle Investment 2011-03-31 Sold Out -0.01%$7.22 - $12.45
($9.95)
$ 4.61-54%Sold Out0
EXELFirst Eagle Investment 2010-12-31 Buy 0.01%$3.98 - $9.08
($5.66)
$ 4.61-19%New holding280,000
EXELFirst Eagle Investment 2009-12-31 Sold Out -0.02%$5.33 - $8
($6.84)
$ 4.61-33%Sold Out0
EXELFirst Eagle Investment 2009-09-30 Buy 0.02%$4.4 - $6.99
($5.65)
$ 4.61-18%New holding274,700
EXELFirst Eagle Investment 2009-06-30 Sold Out -0.01%$4.16 - $5.55
($4.87)
$ 4.61-5%Sold Out0
EXELFirst Eagle Investment 2009-03-31 Reduce$4.32 - $5.85
($4.8)
$ 4.61-4%Reduce -25.67%144,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXEL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EXEL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WILLSEY LANCEDirector 2015-12-11Buy100,000$4.89-5.73view
Lamb PeterEVP, Discovery Research & CSO 2015-10-16Sell51,549$5.8-20.52view
Lamb PeterEVP, Discovery Research & CSO 2015-10-13Sell300,876$5.84-21.06view
MARCHESI VINCENT TDirector 2014-09-17Buy20,000$1.71169.59view
WILLSEY LANCEDirector 2013-08-29Buy10,000$5.15-10.49view
MARCHESI VINCENT TDirector 2012-12-20Buy4,000$4.68-1.5view
MARCHESI VINCENT TDirector 2012-12-19Buy6,000$4.72-2.33view
Schwab GiselaEVP and Chief Medical Officer 2012-12-10Buy25,000$4.395.01view
MARCHESI VINCENT TDirector 2012-06-14Sell7,000$5.13-10.14view
RIVERA LUPE MEVP, Operations 2010-12-17Sell29,427$8.5-45.76view

Quarterly/Annual Reports about EXEL:

News about EXEL:

Articles On GuruFocus.com
The Best-Performing Non-S&P Stocks of 2015 Dec 30 2015 
5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. Sep 28 2014 
Weekly 3-Year Low Highlights: UAN, CLD, EXEL, QNST Sep 06 2014 
Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian Trust, Millennial Media Inc., Exelix May 05 2014 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Exelixis Inc. Reports Operating Results (10-K) Feb 22 2011 
Exelixis Inc. (EXEL) CFO Frank Karbe buys 16,500 Shares Aug 25 2010 
Exelixis Inc. Reports Operating Results (10-Q) Aug 05 2010 
Exelixis Inc. Reports Operating Results (10-Q) May 11 2010 

More From Other Websites
Exelixis to Release First Quarter 2016 Financial Results on Wednesday, May 4, 2016 Apr 26 2016
Exelixis to Release First Quarter 2016 Financial Results on Wednesday, May 4, 2016 Apr 26 2016
Pay Attention to These 5 Stocks Making Big Moves Today Apr 26 2016
Ipsen is pleased to announce that its partner Exelixis obtained FDA Approval of CABOMETYX™... Apr 26 2016
ADDING MULTIMEDIA Exelixis Announces FDA Approval of CABOMETYX™ (Cabozantinib) Tablets for... Apr 25 2016
Peninsula drug developer scores comeback win for cancer-fighting tablet Apr 25 2016
ADDING MULTIMEDIA Exelixis Announces FDA Approval of CABOMETYX™ (Cabozantinib) Tablets for... Apr 25 2016
Exelixis, Inc. Conference Call to Discuss U.S. FDA Approval of CABOMETYX Tablets scheduled for 4:00... Apr 25 2016
Exelixis Gets FDA Approval For Its CABOMETYX Tablets Apr 25 2016
Exelixis Announces FDA Approval of CABOMETYX™ (Cabozantinib) Tablets for Patients with Advanced... Apr 25 2016
Why Are These Stocks Trading Deep in Red on Friday? Apr 22 2016
Exelixis-Discovered Compounds to Be Featured in 18 Presentations at 2016 ASCO Annual Meeting Apr 20 2016
Exelixis-Discovered Compounds to Be Featured in 18 Presentations at 2016 ASCO Annual Meeting Apr 20 2016
Exelixis, Inc. breached its 50 day moving average in a Bullish Manner : EXEL-US : April 5, 2016 Apr 05 2016
Exelixis (EXEL) Stock Climbs, Stifel Upgrades Apr 04 2016
Exelixis upgraded by Stifel Apr 04 2016
Are These Biotech Stocks Worth your Attention? CELG, ARIA, EXEL, and CMRX Mar 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)